Joseph Edelman – APGE history
- Issuer:
- APOGEE THERAPEUTICS INC
- Quarters tracked:
- 11 (Q3 2023 → Q1 2026)
- Current shares:
- 1,540,384
- Current value:
- $129.65M
- Peak shares:
- 2,330,651 (Q4 2025)
- Overall change:
- -16%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 1,540,384 | $129.65M | $84.17 | -790,267 | -34% |
| Q4 2025 | 2,330,651 | $175.92M | $75.48 | +978,662 | +72% |
| Q3 2025 | 1,351,989 | $53.72M | $39.73 | +169,841 | +14% |
| Q2 2025 | 1,182,148 | $51.34M | $43.43 | +59,381 | +5% |
| Q1 2025 | 1,122,767 | $41.95M | $37.36 | +75,535 | +7% |
| Q4 2024 | 1,047,232 | $47.44M | $45.30 | -967,775 | -48% |
| Q3 2024 | 2,015,007 | $118.36M | $58.74 | -90,629 | -4% |
| Q2 2024 | 2,105,636 | $82.86M | $39.35 | +45,241 | +2% |
| Q1 2024 | 2,060,395 | $136.91M | $66.45 | +232,494 | +13% |
| Q4 2023 | 1,827,901 | $51.07M | $27.94 | 0 | 0% |
| Q3 2023 | 1,827,901 | $38.93M | $21.30 | — | NEW |